Tool overview
Ritivel is listed under Healthcare AI tools.
What is Ritivel?
Ritivel is an AI-native regulatory platform for pharmaceutical, biotech, medical-device, CRO, and CDMO teams. It drafts and reviews clinical study reports, CTD modules, IND, NDA, BLA, and related documents with domain-specific AI, source traceability, and fully local or air-gapped deployment.
Best for
Life-science regulatory teams drafting traceable submission documents inside controlled infrastructure
Who is it for?
Decision note
Accepted after independent V411 official-source verification. Run Preview first and visually verify controlled fields, Arabic v2 lists, outreach, affiliate evidence, rebrand or lifecycle status, and logo QA before Apply.
Key features
Clinical study report drafting
CTD Module 2 and Module 5 automation
Word-level source traceability
Domain-trained regulatory language model
Fully local and air-gapped deployment
Use cases
Drafting clinical study reports
Preparing IND, NDA, and BLA modules
Creating CTD summaries
Searching FDA and ICH guidance
Generating safety and briefing documents
Pros
- Built specifically for regulatory writing
- Strong traceability and consistency focus
- Sensitive data stays inside customer infrastructure
Cons
- No public price list
- Enterprise implementation is required
- Generated regulatory text needs expert review
Limitations
Regulatory drafts can contain factual, interpretive, or cross-reference errors. Qualified regulatory, medical-writing, statistical, quality, and legal reviewers must validate every claim, source, table, and submission requirement before filing.
Pricing details
Billing options
Enterprise custom
Pricing note
Ritivel does not publish public plan prices. The official website directs pharmaceutical, biotech, medtech, CRO, and CDMO organizations to book a demo for an enterprise deployment. No public free plan or free-trial terms were confirmed.
Supported languages
- English
Please log in to join the discussion.